Chesnara Plc: Fourth acquisition in two years
12 November 2026
Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $9.46 billion,..
Illumina, Inc. (ILMN) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $15.96 billion,..
Bio-Techne Corp (NASDAQ: TECH), a leading player in the biotechnology sector, has captured investor attention with its robust market presence and promising growth potential. With a..
Investors with an eye on the biotechnology sector should take a closer look at Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage precision oncology company that is..
ResMed Inc. (NYSE: RMD), a leading player in the healthcare sector, is capturing the attention of investors with a market cap of $37.68 billion and a..
Telix Pharmaceuticals Limited (TLX) is emerging as a compelling player in the biotechnology sector, with its promising portfolio of radiopharmaceutical products and impressive market performance. Based..
Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector specializing in medical devices, offers an intriguing opportunity for investors with a potential upside of..
Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, is making waves with its strategic focus on women’s health and its diversified portfolio of..
For investors with an eye on the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) offers a compelling opportunity. With a market capitalization of $11.03 billion, BioMarin..
Qiagen N.V. (QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers an intriguing proposition for investors eyeing steady growth..
Haleon plc (HLN), a stalwart in the healthcare sector, commands significant attention from investors with its market cap standing robustly at $46.04 billion. As a prominent..
Encompass Health Corporation (NYSE: EHC), a leading provider of post-acute healthcare services, has captured investor attention with an enticing potential upside of 10.54%. With its market..
Roivant Sciences Ltd. (NASDAQ: ROIV) is intriguing investors with its promising potential upside of 52.41%, according to the latest analyst ratings. As a clinical-stage biopharmaceutical company,..
Summit Therapeutics Inc. (NASDAQ: SMMT) presents an intriguing proposition for investors seeking to capitalize on the biotechnology sector’s growth potential. This Miami-based biopharmaceutical company, with a..
In the ever-evolving realm of healthcare, Globus Medical, Inc. (NYSE: GMED) stands out as a key player within the medical devices industry. With its innovative solutions..
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands out in the biotech sector with a compelling narrative for investors, driven by its focus on innovative treatments for metabolic..
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable entity in the biotechnology sector, with a specific focus on groundbreaking therapies for cystic fibrosis (CF). Headquartered..
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a prominent biopharmaceutical company that has carved a niche in the healthcare sector by focusing on developing innovative treatments for..
Option Care Health, Inc. (NASDAQ: OPCH), a pivotal player in the healthcare sector, is making waves with its robust growth potential and strong analyst ratings. With..
Agilent Technologies, Inc. (NYSE: A), a global leader in providing application-focused solutions for the life sciences, diagnostics, and applied chemical markets, presents an intriguing opportunity for..
